Market Value5,447,026,000
Total Holdings81
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GILD / Gilead Sciences, Inc.
HOOK / HOOKIPA Pharma Inc.
QURE / uniQure N.V.
HRC / Hill-Rom Holdings Inc
BURNING ROCK BIOTECH LTD / SPONSORED ADS (12233L107)
US74257L1089 / Principia Biopharma Inc.
US29266S3040 / Endologix, Inc.
CYRX / Cryoport, Inc.
RPRX / Royalty Pharma plc
GDRX / GoodRx Holdings, Inc.
OM / Outset Medical, Inc.
AMED / Amedisys, Inc.
OVID / Ovid Therapeutics Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
STOK / Stoke Therapeutics, Inc.
CSLT / Castlight Health Inc - Class B
/ Pandion Therapeutics Inc
EPZM / Epizyme Inc
SYRS / Syros Pharmaceuticals, Inc.
ODT / Odonate Therapeutics Inc
US3723091043 / GenMark Diagnostics, Inc
NVRO / Nevro Corp.
GMTX / Gemini Therapeutics Inc
CLDX / Celldex Therapeutics, Inc.
ADCT / ADC Therapeutics SA
TWST / Twist Bioscience Corporation
FOLD / Amicus Therapeutics, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
AXNX / Axonics, Inc.
GMXAY / Genmab A/S
IMTX / Immatics N.V.
RCEL / AVITA Medical, Inc.
GH / Guardant Health, Inc.
US55027E1029 / Luminex Corporation
IMVT / Immunovant, Inc.
VAPO / Vapotherm, Inc.
US69354M1080 / PRA Health Sciences Inc
SNY / Sanofi - Depositary Receipt (Common Stock)
PROF / Profound Medical Corp.
/ Immunomedics, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
PPD / PPD Inc
US60877T1007 / Momenta Pharmaceuticals, Inc.
MRK / Merck & Co., Inc.
SLQT / SelectQuote, Inc.
ALVR / AlloVir, Inc.
UNH / UnitedHealth Group Incorporated
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
TCRR / Tcr2 Therapeutics Inc
AYLA / Ayala Pharmaceuticals Inc
ARGX / argenx SE - Depositary Receipt (Common Stock)
RIGL / Rigel Pharmaceuticals, Inc.
BIIB / Biogen Inc.
ICUI / ICU Medical, Inc.
CI / The Cigna Group
PAYX / Paychex, Inc.
OSH / Oak Street Health Inc
ZNTL / Zentalis Pharmaceuticals, Inc.
APRE / Aprea Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
CTSO / Cytosorbents Corporation
BCEL / Atreca, Inc.
ONEM / 1life Healthcare Inc
ZYME / Zymeworks Inc.
WVE / Wave Life Sciences Ltd.
ALLK / Allakos Inc.
ARDX / Ardelyx, Inc.
CBAY / CymaBay Therapeutics, Inc.
REPL / Replimune Group, Inc.
PLRX / Pliant Therapeutics, Inc.
BSX / Boston Scientific Corporation
DVAX / Dynavax Technologies Corporation
DXCM / DexCom, Inc.
IMGN / ImmunoGen, Inc.
XERS / Xeris Biopharma Holdings, Inc.
STXS / Stereotaxis, Inc.
NVTA / Invitae Corporation
DCPH / Deciphera Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
CTLT / Catalent, Inc.
SRRK / Scholar Rock Holding Corporation
ANNX / Annexon, Inc.
IGMS / IGM Biosciences, Inc.
KRYS / Krystal Biotech, Inc.
RGNX / REGENXBIO Inc.
NRIX / Nurix Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
AKRO / Akero Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
ATRA / Atara Biotherapeutics, Inc.
CABA / Cabaletta Bio, Inc.
GRTSQ / Gritstone bio, Inc.
ALXO / ALX Oncology Holdings Inc.